BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 1, 2008
View Archived Issues
Duloxetine effective in reducing osteoarthritis knee pain
Read More
Exelixis and GSK to conclude 6-year collaboration as scheduled in October 2008
Read More
FDA approves Metvixia and aktilite CL-128 for actinic keratosis
Read More
Three-month safety and efficacy data reported for Medidur FA
Read More
Snapshots: New data on lenalidomide development
Read More
Preclinical results support accelerated development of iCo-009
Read More
Canadian clearance for phase II study of TLN-232 in metastatic melanoma
Read More
NIH awards phase II SBIR grant to Pressure BioSciences to develop PCT
Read More
Schering-Plough and Merck withdraw loratadine/montelukast NDA and terminate joint venture
Read More
Dako enters collaboration with Bristol-Myers for pharmacodiagnostic tests for cancer patients
Read More
Greer completes enrollment in phase III clinical trial of SLIT for short ragweed allergies
Read More
Action starts phase II trial with AP-214 for organ failure associated with surgery
Read More
Affymax initiates enrollment in phase II Hematide trial
Read More
New agents for periodontitis imparted in recent patent
Read More
Recent sanofi-aventis patent discloses novel antithrombotic agents
Read More
Recent patents describe novel antidiabetic agents
Read More
Catalyst commences enrollment for U.S. phase II CPP-109 trial in addiction
Read More
Centocor submits BLA to FDA requesting approval of golimumab
Read More
A novel ACE2 activator shows benefit in experimental pulmonary hypertension
Read More
Novexel discontinues development of antibiotic NXL-101
Read More
Peregrine doses first patient in phase II bavituximab trial in NSCLC
Read More
RP-193, a novel CFTR activator enhances chloride secretion in vitro
Read More
Takeda submits NDA in Japan for panitumumab
Read More
Cytokinetics reports promising data for ispinesib in combination with capecitabine
Read More
Neuren to finish phase III Glypromate trial 6 months ahead of schedule
Read More
Intellect and MRC Technology achieve milestone in Alzheimer's therapeutic antibody program
Read More